Category Archives: Drug Discovery

William Haseltine, PhD, President ACCESS Health International

How Has Covid-19 Changed Science?

 Andrea Macdonald, founder of ideaXme interviews Dr. William A. Haseltine, President ACCESS Health International. In this interview William Haseltine talks of: -How Covid-19 has changed science -How high levels of scientific collaboration and knowledge sharing were sparked in this crisis and a precedent set in which it has become institutionalised within the “virus science” […]

Dr. Steffanie Strathdee and her husband.

The Killer and the Perfect Predator: Bacteriophages

Ira Pastor, ideaXme exponential health ambassador and founder of Bioquark interviews Dr. Steffanie Strathdee, Associate Dean of Global Health Sciences and Harold Simon Professor in the Department of Medicine at the University of California San Diego School of Medicine. Ira Pastor comments: So here we are in 2019, and although we spend a lot of […]

Dr Dennis McKenna, Founder at Symbio Life Sciences, PBC.

Psychedelic Drugs: Mainstream Medicines of the Future?

Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark interviews Dr Dennis McKenna, Founder at Symbio Life Sciences PBC. Dennis McKenna has pursued interdisciplinary research focusing on Amazonian ethnopharmacology and plant hallucinogens for over 30 years. He has investigated the potential of psychedelic drugs to help address human health challenges. Please note, this content […]

Dr. Shai Shen-Orr, Founder and Chief Scientist of CytoReason and Associate Professor Technion, Israel Institute of Technology.

CytoReason: Artificial Intelligence Crunches Data and Speeds Up Drug Discovery

Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark interviews Dr. Shai Shen-Orr, Founder and Chief Scientist of CytoReason and Associate Professor Technion, Israel Institute of Technology. Ira Pastor comments: The year is now 2019 and we have surpassed $7 trillion in total annual healthcare expenditures around the globe. As part of that […]

LaMattina

Drug Discoveries: Translation to Disease Management Protocols for Patients

Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark interviews John LaMattina, Senior Partner PureTech Health and former President of R&D Pfizer. They talk of drug discoveries and treatments and the process of translating them to disease management protocols for patients. Ira Pastor comments: On the last few shows, we have spent time […]

The WAR on Cancer #2: Integrated Prevention

The WAR on Cancer #2: Integrated Prevention, Diagnosis and Therapy

Dr Dario Altieri and his War on Cancer Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark, interviews Dr. Dario Altieri, President and Chief Executive Officer The Wistar Institute and Director Wistar Cancer Center. They talk of integrated prevention, diagnosis and therapy to fight the war on cancer. Discover Dr Altieri’s career, scientific […]